Alembic Pharmaceuticals has received USFDA approval for Temazepam capsules which is used for the treatment of insomnia. The drug will be made available in strengths of 7.5mg, 15mg, 22.5mg and 40mg.
According to market estimates, Temazepam capsules 7.5mg, 15mg, 22.5mg and 40mg had an estimated market size of $48 million for the 12 months ended December 2017.
Company Profile : Alembic Pharmaceuticals Ltd
Leave a Reply